BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 18, 2009
View Archived Issues
Naltrexone implant shown to be safe and effective in heroin dependence
Read More
Novel bacterial signal transduction inhibitors in development at Kinki University
Read More
France grants marketing authorization to Sanofi's Panenza influenza vaccine
Read More
Exclusive licensing agreement signed to market Zolpimist in U.S. and Canada
Read More
FDA approves NeurogesX's Qutenza for neuropathic pain due to postherpetic neuralgia
Read More
ARCA biopharma to submit study protocol for Gencaro trial under the FDA's SPA
Read More
PPD and Janssen to develop two phase II drugs for IBS-D and bacterial infections
Read More
Novartis reports interim data from ongoing clinical trials of influenza A vaccine
Read More
GP Pharm files NDA for Lutrate in five European countries
Read More
Data from phase III trials support safety and efficacy of tenofovir DF in CHB patients
Read More
Clinical data reported for boceprevir plus PegIntron/ribavirin in HCV
Read More
Rifaximin exhibits durable long-term protection in hepatic encephalopathy trial
Read More
Clinical data presented from 3 trials on sorafenib for HCC therapy
Read More
Cosmo Pharmaceuticals offers to acquire BioXell
Read More
Phase I data on JNJ-26483327 in solid tumors reported at 2009 AACR-NCI-EORTC meeting
Read More
Gruenenthal presents a new series of ORL1 and mu-opioid receptor ligands
Read More
Glucokinase activators for the treatment of diabetes described by Merck KGaA
Read More
FDA approves GlaxoSmithKline's pandemic H1N1 vaccine
Read More
New mGluR2 receptor ligands for the treatment of epilepsy disclosed by sanofi-aventis
Read More
Genentech submits sBLAs to FDA for first-line Avastin treatment of breast cancer
Read More
NeuroSearch claims novel dopamine and serotonin receptor modulators
Read More
Medical Therapies becomes Cellmid
Read More
Sequella and NIH sign new exclusive worldwide licensing agreement for SQ-109
Read More
FDA committee to review OSI's Tarceva as first-line maintenance therapy for NSCLC
Read More
FDA grants EUA to Roche's RealTime Ready Influenza A/H1N1 Detection Set
Read More
FDA accepts for filing NicOx's NDA for naproxcinod in osteoarthritis
Read More